News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Corindus Release: Robotic-Assisted PCI Takes the Stage at TCT 2012



10/19/2012 10:11:37 AM

NATICK, Mass., Oct. 18, 2012 /PRNewswire/ -- Corindus Vascular Robotics, a developer of precision vascular robotics, today announced leading experts in interventional cardiology will speak about their clinical experience using the CorPath® 200 System at this year's Transcatheter Cardiovascular Therapeutics' annual meeting, TCT 2012.

(Photo: http://photos.prnewswire.com/prnh/20121018/NE95678-a )
(Logo: http://photos.prnewswire.com/prnh/20121018/NE95678LOGO-b )

As part of TCT's scientific symposia "Interventional Innovation: Novel Therapies and the "Best" New Device Concepts for 2012," Giora Weisz, M.D., director of Clinical Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and associate professor of Medicine at Columbia University College of Physicians and Surgeons, New York will present a taped case and discussion titled "The Corindus Robotic-Assisted Coronary Angioplasty System."

"Robotic-assisted PCI's will revolutionize the way interventional cardiologists perform the procedure," said Dr. Weisz. "The case presentation will highlight my clinical use of the CorPath 200 System and how in my experience robotic-assisted PCI is safe and provides enhanced precision and control of the guidewire, balloon and stent. Additionally, sitting comfortably during the procedure, without the need for a lead apron and in proximity to the monitors, allows me to improve visualization of the treatment targets. Improved measurement and visualization is important as 10-20 percent of patients require a second stent due to inaccurate placement or size of the first stent."

Additionally, Corindus Vascular Robotics and Philips Healthcare will co-sponsor a symposium, "Introducing Robotic-Assisted PCI into Your Cath Lab Practice." The event will take place on Thursday, October 25 at 7:00 a.m. EDT at theMiami Beach Convention Center. Moderated by Peter J. Fitzgerald, M.D., Stanford University and Dr. Weisz, the symposium will include presentations on the benefits of robotic-assisted percutaneous coronary intervention (PCI) procedures, followed by a roundtable discussion. Presentations include:

  • "CorPath 200 System Overview-Robotic-assisted PCI" George Vetrovec, M.D., VCU Medical Center
  • "The PRECISE Final Results" Giora Weisz, M.D., NewYork-Presbyterian Hospital/Columbia University Medical Center
  • "A Day in a CorPath Lab: Treating Different Patients with a Robotic System" J. Jeffrey Marshall, M.D., FACC, FSCAI, North East Georgia Medical Center
  • "Robotics in the Cath Lab: Hospital's Perspective" Joseph P. Carrozza Jr., M.D., Steward St. Elizabeth's Medical Center and Tufts University Medical School

"Receiving FDA clearance earlier this year for the CorPath 200 System, TCT 2012 marks an exciting opportunity to educate interventional cardiologists not only about the benefits of the CorPath 200 System, but its use in clinical practice," said David Handler, CEO of Corindus Vascular Robotics. "Several leading medical centers have already adopted the CorPath 200 System to enhance their hospital's cardiology programs. The adoption and excitement for the technology further solidifies our belief that the CorPath will change standard of care, and improve safety and the quality of care in the cath lab." 

To learn more about Corindus Vascular Robotics or to book a hands-on demonstration of the CorPath 200 System at Corindus' booth (exhibit hall booth 215) at TCT 2012, please call 508.653.3335 x200 or email TCT2012@corindus.com.

About Corindus Vascular Robotics
Corindus Vascular Robotics (http://www.corindus.com) is the global technology leader in robotic-assisted percutaneous coronary interventions (PCI). The Company's FDA cleared CorPath® 200 System is the first medical device that offers interventional cardiologists PCI procedure control from an interventional cockpit. The CorPath open-platform technology and intellectual property will enable Corindus to address other segments of the vascular market, including peripheral, neuro and structural heart applications.

Media Contacts:


Corindus Vascular Robotics

Schwartz MSL

Tal Wenderow

Krystin Hayward/Kirsten Fallon

(508) 653-3335 ext. 205

(781) 684-0770

Tal.Wenderow@corindus.com

corindus@schwartzmsl.com

SOURCE Corindus Vascular Robotics


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES